 | HGC019 is a mRNA and Self-amplifying mRNA (saRNA) based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with... 6 KB (362 words) - 16:05, 7 October 2023 |
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)... 337 KB (26,266 words) - 22:31, 24 April 2024 |
 | Capacity BBV154 Adenovirus vector (intranasal) Completed In progress Pending 175 100 million HGC019 mRNA Completed In progress Pending 120 60 million... 140 KB (9,633 words) - 19:57, 21 April 2024 |
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)... 13 KB (1,241 words) - 00:29, 15 December 2023 |
Inactivated KD-414 NDV-HXP-S RNA ARCT-021 ARCT-154 Bangavax CureVac (terminated) HGC019 mRNA-1283 PTX-COVID19-B Sanofi–Translate Bio (terminated) Stemirna COVID-19... 181 KB (23,901 words) - 14:23, 6 January 2024 |
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)... 7 KB (260 words) - 15:20, 22 April 2023 |
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)... 6 KB (371 words) - 05:00, 23 March 2023 |
| Press Information Bureau. Retrieved 13 January 2021. "mRNA Vaccines – HGC019". Gennova Biopharmaceuticals Limited. Retrieved 13 January 2021. "Safety... 98 KB (20,593 words) - 02:58, 8 March 2024 |